FGFBP2 and neoplasm: Using multiplex IHC assays, we showed that FGFBP2+NKT cells (positive for CD8, NCAM1, and FGFBP2, but not for CD4) were mainly present in the para-tumor regions and were sparsely distributed in the tumor regions (Fig. 5j).